Literature DB >> 21084484

Viral exploitation of host SOCS protein functions.

Lisa Nowoslawski Akhtar1, Etty N Benveniste.   

Abstract

Over the past decade, a family of host proteins known as suppressors of cytokine signaling (SOCS) have emerged as frequent targets of viral exploitation. Under physiologic circumstances, SOCS proteins negatively regulate inflammatory signaling pathways by facilitating ubiquitination and proteosomal degradation of pathway machinery. Their expression is tightly regulated to prevent excessive inflammation while maintaining protective antipathogenic responses. Numerous viruses, however, have developed mechanisms to induce robust host SOCS protein expression following infection, essentially "hijacking" SOCS function to promote virus survival. To date, SOCS proteins have been shown to inhibit protective antiviral signaling pathways, allowing viruses to evade the host immune response, and to ubiquitinate viral proteins, facilitating intracellular viral trafficking and progeny virus assembly. Importantly, manipulation of SOCS proteins not only facilitates progression of the viral life cycle but also powerfully shapes the presentation of viral disease. SOCS proteins can define host susceptibility to infection, contribute to peripheral disease manifestations such as immune dysfunction and cancer, and even modify the efficacy of therapeutic interventions. Looking toward the future, it is clear that a better understanding of the role of SOCS proteins in viral diseases will be essential in our struggle to modulate and even eliminate the pathogenic effects of viruses on the host.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21084484      PMCID: PMC3067810          DOI: 10.1128/JVI.01857-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  78 in total

1.  A longitudinal study of neutralizing antibodies and disease progression in HIV-1-infected subjects.

Authors:  D Cecilia; C Kleeberger; A Muñoz; J V Giorgi; S Zolla-Pazner
Journal:  J Infect Dis       Date:  1999-06       Impact factor: 5.226

Review 2.  How cells respond to interferons.

Authors:  G R Stark; I M Kerr; B R Williams; R H Silverman; R D Schreiber
Journal:  Annu Rev Biochem       Date:  1998       Impact factor: 23.643

3.  Enhanced expression of suppressor of cytokine signalling-1 in the liver of chronic hepatitis C: possible involvement in resistance to interferon therapy.

Authors:  K Imanaka; S Tamura; K Fukui; N Ito; S Kiso; Y Imai; T Naka; T Kishimoto; S Kawata; Y Shinomura
Journal:  J Viral Hepat       Date:  2005-03       Impact factor: 3.728

4.  Induction of hyper Th1 cell-type immune responses by dendritic cells lacking the suppressor of cytokine signaling-1 gene.

Authors:  Toshikatsu Hanada; Kentaro Tanaka; Yumiko Matsumura; Moriyasu Yamauchi; Hitomi Nishinakamura; Hiroyuki Aburatani; Ryuichi Mashima; Masato Kubo; Takashi Kobayashi; Akihiko Yoshimura
Journal:  J Immunol       Date:  2005-04-01       Impact factor: 5.422

5.  Induction of suppressor of cytokine signaling-3 by herpes simplex virus type 1 confers efficient viral replication.

Authors:  Shin-ichi Yokota; Noriko Yokosawa; Tamaki Okabayashi; Tatsuo Suzutani; Nobuhiro Fujii
Journal:  Virology       Date:  2005-07-20       Impact factor: 3.616

6.  Gamma interferon can block herpes simplex virus type 1 reactivation from latency, even in the presence of late gene expression.

Authors:  Vilma Decman; Paul R Kinchington; Stephen A K Harvey; Robert L Hendricks
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

7.  Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells.

Authors:  Ya-Lin Chiu; Vanessa B Soros; Jason F Kreisberg; Kim Stopak; Wes Yonemoto; Warner C Greene
Journal:  Nature       Date:  2005-04-13       Impact factor: 49.962

8.  Silencing of SOCS1 enhances antigen presentation by dendritic cells and antigen-specific anti-tumor immunity.

Authors:  Lei Shen; Kevin Evel-Kabler; Randy Strube; Si-Yi Chen
Journal:  Nat Biotechnol       Date:  2004-11-21       Impact factor: 54.908

9.  Molecular analysis of human cancer cells infected by an oncolytic HSV-1 reveals multiple upregulated cellular genes and a role for SOCS1 in virus replication.

Authors:  Y Y Mahller; B Sakthivel; W H Baird; B J Aronow; Y-H Hsu; T P Cripe; R Mehrian-Shai
Journal:  Cancer Gene Ther       Date:  2008-06-13       Impact factor: 5.987

10.  Influenza A virus inhibits type I IFN signaling via NF-kappaB-dependent induction of SOCS-3 expression.

Authors:  Eva-K Pauli; Mirco Schmolke; Thorsten Wolff; Dorothee Viemann; Johannes Roth; Johannes G Bode; Stephan Ludwig
Journal:  PLoS Pathog       Date:  2008-11-07       Impact factor: 6.823

View more
  57 in total

1.  SOCS1/3 expression levels in HSV-1-infected, cytokine-polarized and -unpolarized macrophages.

Authors:  Adam Craig Reichard; Nagarjuna Reddy Cheemarla; Nancy Jane Bigley
Journal:  J Interferon Cytokine Res       Date:  2014-06-23       Impact factor: 2.607

2.  Leukemia Inhibitory Factor Inhibits Plasmacytoid Dendritic Cell Function and Development.

Authors:  Renata Sesti-Costa; Luisa Cervantes-Barragan; Melissa K Swiecki; José Luís Fachi; Marina Cella; Susan Gilfillan; João Santana Silva; Marco Colonna
Journal:  J Immunol       Date:  2020-03-13       Impact factor: 5.422

3.  SOCS1 abrogates IFN's antiviral effect on hepatitis C virus replication.

Authors:  Run-Xuan Shao; Leiliang Zhang; Zhi Hong; Kaku Goto; Du Cheng; Wen-Chi Chen; Nikolaus Jilg; Kattareeya Kumthip; Dahlene N Fusco; Lee F Peng; Raymond T Chung
Journal:  Antiviral Res       Date:  2012-12-10       Impact factor: 5.970

4.  Murine cytomegalovirus downregulates interleukin-17 in mice with retrovirus-induced immunosuppression that are susceptible to experimental cytomegalovirus retinitis.

Authors:  Emily L Blalock; Hsin Chien; Richard D Dix
Journal:  Cytokine       Date:  2013-02-14       Impact factor: 3.861

5.  Suppressors of cytokine signaling 1 and 3 are upregulated in brain resident cells in response to virus-induced inflammation of the central nervous system via at least two distinctive pathways.

Authors:  Maria Abildgaard Steffensen; Christina Fenger; Jeanette Erbo Christensen; Carina Krogsgaard Jørgensen; Maria Rosaria Bassi; Jan Pravsgaard Christensen; Bente Finsen; Allan Randrup Thomsen
Journal:  J Virol       Date:  2014-09-24       Impact factor: 5.103

Review 6.  SOCS3 revisited: a broad regulator of disease, now ready for therapeutic use?

Authors:  R Mahony; S Ahmed; C Diskin; N J Stevenson
Journal:  Cell Mol Life Sci       Date:  2016-05-02       Impact factor: 9.261

7.  Transcriptomic analysis of the woodchuck model of chronic hepatitis B.

Authors:  Simon P Fletcher; Daniel J Chin; Yongmei Ji; A Leonardo Iniguez; Bruce Taillon; David C Swinney; Palanikumar Ravindran; Donavan T Cheng; Hans Bitter; Uri Lopatin; Han Ma; Klaus Klumpp; Stephan Menne
Journal:  Hepatology       Date:  2012-07-12       Impact factor: 17.425

8.  Heartland virus antagonizes type I and III interferon antiviral signaling by inhibiting phosphorylation and nuclear translocation of STAT2 and STAT1.

Authors:  Kuan Feng; Fei Deng; Zhihong Hu; Hualin Wang; Yun-Jia Ning
Journal:  J Biol Chem       Date:  2019-04-30       Impact factor: 5.157

9.  Suppressor of Cytokine Signaling 1 (SOCS1) and SOCS3 Are Stimulated within the Eye during Experimental Murine Cytomegalovirus Retinitis in Mice with Retrovirus-Induced Immunosuppression.

Authors:  Hsin Chien; Christine I Alston; Richard D Dix
Journal:  J Virol       Date:  2018-08-29       Impact factor: 5.103

Review 10.  Building and remodelling Cullin-RING E3 ubiquitin ligases.

Authors:  John R Lydeard; Brenda A Schulman; J Wade Harper
Journal:  EMBO Rep       Date:  2013-11-15       Impact factor: 8.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.